SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,774 JPY | -3.71% |
|
-7.46% | -0.35% |
| 14/05 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| 13/05 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
07/06/2024
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6,774
JPY
Average target price
7,867
JPY
Spread / Average Target
+16.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.35% | 12.77B | |
| +37.74% | 723B | |
| +32.22% | 598B | |
| -2.07% | 364B | |
| +20.25% | 331B | |
| +2.99% | 288B | |
| +16.60% | 244B | |
| +9.77% | 210B | |
| -5.15% | 208B | |
| +7.43% | 169B |
- Stock Market
- Equities
- 4507 Stock
- Funds and ETFs Shionogi & Co., Ltd.
